Abstract-It has been reported that leukotrienes (LTs) may play a role in inflam matory liver diseases, and several inhibitors of LTs show an inhibitory effect on experimental liver injuries. In this study, the effect of Gomisin A (TJN-101), which is a lignan component of schisandra fruits, on the arachidonic acid cascade in macrophages was examined to explain the mechanisms of the inhibitory effect of TJN-101 on liver injuries. The production of leukotriene B4 was suppressed by treatment with TJN-101, while the activity of 5-lipoxygenase was not affected. The release of arachidonic acid from macrophages stimulated with fMet-Leu-Phe or the Ca" lonophore A23187 was suppressed by treatment with TJN-101. The activity of phospholipase A2 was not affected by treatment with TJN-101. These results suggested that TJN-101 produces an inhibitory effect on the biosynthesis of LTs by preventing the release of arachidonic acid, and it was thought that the preventive effect on the arachidonic acid cascade may be partially associated with the inhibitory effect of TJN-101 on liver injuries.
Gomisin A (TJN-101), a lignan component of schisandra fruits (1) , has been known to prevent liver injuries induced by hepatotoxic chemicals (2) (3) (4) (5) . We have previously reported that TJN-101 reduced the mortality of mice with immunological acute hepatic failure ex perimentally induced by the injection of heat killed Propionibacterium aches (P. aches) and a small dose of lipopolysaccharide (6) . TJN 101 also prevented the isolated liver cell in juries caused by the culture supernatant con taining cytotoxic factors from the antibody dependent cell-mediated cytotoxic reaction mixture or activated macrophages reaction mixture in vitro (6, 7) . These findings suggest that TJN-101 has a protective effect against liver cell injuries caused by cytotoxic factors from immunological reactions.
Leukotrienes (LTs) are potent inflammatory agents that are synthesized by the lipoxygen ase pathway. Recently, it has been reported that LTs may play a role in inflammatory liver diseases (8) . In immunological acute hepatic failure, mononuclear cells (e.g., monocytes and macrophages) are infiltrated in the liver lobules by the injection of heat-killed P. aches (9) (10) (11) (12) , and these cells are the predominant cells producing LTs (13, 14) . Kupffer cells, which are resident hepatic macrophages, have also been shown to release LTs (15, 16) . Another report has suggested that the induc tion of immunological acute hepatic failure is suppressed by treatment with 5-lipoxygenase inhibitors (17) . In this study, the effect of TJN-101 on the arachidonic acid cascade in macrophages was examined to explain the mechanisms of the inhibitory effect of TJN 101 on liver injuries.
Materials and Methods

Materials
The chemical structure of TJN-101 is shown in Fig. 1 (18) . The cells were washed and suspended in RPMI 1640 solu tion containing 1 % BSA, 100 units/ml of penicillin, and 100 /tg/ml of streptomycin. The cell concentration was adjusted to 1 X107 cells/ml, and I O,al of ethanol or various con centrations of TJN-101 solution was added to 1 ml of cell suspension. After incubation at 37'C for 12 hr in a humidified cell-incubator with aeration by 5% CO2 in air, the cells were washed and resuspended in Gey's buffer con taining 1 % BSA. The amount of LTB4 was measured with the LTB4 [3H] RIA kit after stimulation of the cells with 1 ,eM of Ca++ ionophore A23187 at 37'C for 20 min.
2. 5 Li poxygenase activity: 5 Li poxyge n ase activity was measured by the previously described method (19) . Rat peritoneal macro phages, prepared as described above, were suspended in 0.05 M phosphate buffer con taining 1 mM EDTA and 0.1% gelatin. The cells were homogenized and centrifuged at 105,000 g for 10 min. The resulting superna tant was incubated with 0.2 ,rtCi of (1 -14C) arachidonic acid, 0.8 mM of CaCl2, 2X10-5 M of indomethacin, and various concentra tions of TJN-101 solution at 37°C for 5 min. After the incubation, the reaction was termi nated by adjusting the pH of the mixture to 3.0 with HCI, and the mixture was extracted with 8 volumes of ethyl acetate. The lipid extract, after evaporation under a stream of N2, was chromatographed on a silica gel G plate and was separated using the solvent system of petroleum ether/ether/acetic acid (50:50:1). Labeled substrate and standards were localized by autoradiography or iodine vapor and scraped off for liquid scintilation counting. The activity of 5-lipoxygenase was expressed as the radioactivity of 5-HETE.
3. Release of arachidonic acid: The release of arachidonic acid was measured according to the method of Hirata et al. (20) . Male Hartley strain guinea pigs, weighing about 450 g, were used. Five milliliters of Marcol 52 was injected into the peritoneal cavity. Peri toneal exudate cells were collected 4 days later by the method described above. The cells were suspended at a concentration of 5 X 106 cells/ml and incubated for 12 hr. After in cubation, the cells were washed with Gey's buffer containing 1 % BSA and resuspended in the same buffer. Each cell suspension was incubated with 0.25 ,eCi of (1-14C)arachido nic acid for another 1 hr, and then the cells were washed. The cells were resuspended in the same buffer, and each cell suspension was incubated with 10 nM of biologically active peptide, fMet-Leu-Phe (20) , or 1 uM of Ca" ionophore A23187 for 10 min. Five percent of trichloroacetic acid solution (0.5 ml) was added to each suspension and centrifuged at 10,000 g for 20 min. The radioactivity of the resulting supernatant was measured by a liquid scintillation counter.
4. PLA2 activity: The activity of PLA2 was measured using L-a-l-palmitoyl-2-(1-14C) arachidonyl phosphatidylcholine as the sub strate. The reaction mixture containing 0.2 ,aM of radioactive substrate, 0.05 /cg of porcine pancreatic PLA2, and various concen trations of TJN-101 solution were incubated at 37°C for 5 min. After incubation, the reac tion was terminated by 3 ml of Dole's reagent (21, 22) . The activity of PLA2 was determined by the release of (1 -14C)arachidonic acid from the substrate.
5. Statistical analysis: Results were ex pressed as means±S.E. Statistical evaluation was performed by an analysis of variance. If the F values indicated statistically signifi cances, a statistical analysis of the data was made by Student's t-test.
Results
Effect on the production of LTB4:
A cell population consisting of more than 90% macrophages was used, and cell viability was approx. 90-95%, as assessed by the trypan blue test. When the cells were incubated for 12 hr, cell viability was maintained at more than 90%, and it was not affected by treatment with TJN-101 (data not shown).
The production of LTB4 in the macrophages is shown in Fig. 2 . The production without stimulation by the Call ionophore A231 87 was 2.6+0.1 X102 pg/107 cells (n=5), and this production was increased to 11.4±0.2x 102 pg/10' cells (n=5) by stimulation with the ionophore. Treatment with 1 X10-4 g/ml of TJN-101 reduced this increase by about 50%.
2. Effect on the activity of 5-lipoxygenase: When the lipid extract, which was extracted from the reaction mixture of the cytosolic fraction of macrophages and 14C-arachidonic acid, was separated using TLC, the radioactive spots obtained corresponded to standard 5 HETE (Rf=0.37), 12 or 15-HETE (Rf=0.69), arachidonic acid and other lipids. 12-HETE and 15-HETE were not separated in this system. The amount of 5-HETE produced was 2.2±0.3x103 cpm/ml (n=5), and it was about 2.5-fold higher than the amounts of 12 and 15-HETE. The effect of TJN-101 on the activity of 5-lipoxygenase was expressed as the production of 5-HETE. The production of 5-HETE was not affected by treatment with TJN-101 (Fig. 3) .
3. Effect on the release of arachidonic acid: Arachidonic acid is released from the cell membrane by stimulation with fMet-Leu-Phe (20) or Call ionophore A23187, and the release of arachidonic acid from the cell mem brane was studied using a radiolabeled sub strate. (1 14C)arachidonic acid, which was incubated with macrophages for 1 hr; About 25% of the radiolabeled substrate was in Fig. 2 corporated into the cells, and this was not affected by treatment with TJ N-101 (data not shown). In the control group, the release of (1 -14C)arachidonic acid stimulated with fMet-Leu-Phe was 4.7±0.2 x 103 cpm/5 x 106 cells (n=6). This release of arachidonic acid from macrophages was markedly sup pressed by TJN-101 treatment. As higher concentrations of TJN-101 were added, the release was more suppressed. When the macrophages were stimulated with the Ca" ionophore A23187, the release of (1-14C) arachidonic acid in the control group was 3.1 ±0.4 x 103 cpm/5 x 106 cells (n=6). The release was prevented by treatment with TJ N 101 ( Table 1) .
4. Effect on the activity of PLA2: Arachido nic acid is hydrolyzed from the (3-position of phosphatidylcholine by incubation with PLA2 in vitro. This hydrolysis was 4.2±1.6 x 106 cpm/mg protein/min (n=6), and it was not affected by treatment with TJN-101 at the dose of 1 x 10-7 to 1 x 10-4 g/ml (Fig. 4) . Discussion TJN-101 shows an inhibitory effect on liver cell injuries induced by various hepato toxic chemicals (2) (3) (4) (5) , and it also prevents liver injuries caused by immunological reac tions in vivo and in vitro (6, 7) . From these findings, it was thought that TJN-101 pro tects the liver cells from cytotoxicities. LTs are synthesized by the lipoxygenase pathway in various tissues (13, 14) and thought to be the primary mediator of inflammation. Recent ly, it has been reported that LTs may play a role in inflammatory liver diseases (8) . Several inhibitors of LTs synthesis were found to sup press liver injuries induced by D-galactos amine (23) or a-amanitine (18) . Another report has shown that immunological acute hepatic failure is inhibited by treatment with a 5-lipoxygenase inhibitor (17) , and TJN-101 also has an inhibitory effect on this hepatic failure (6) . This injury is induced by cytotoxic factors from mononuclear cells (e.g., monocy tes and macrophages), which are infiltrated in the liver lobules, and these cells are the pre dominant cells producing LTs (13, 14) . In this study, the effect of TJN-101 on the arachi donic acid cascade using macrophages, which is a one of these infiltrated mononuclear cells, was examined to clarify the mechanisms of the inhibitory effect of TJN-101 on liver injuries.
When the macrophages were incubated with TJN-101, the production of LTB4 caused bystimulationwith the Ca" lonophore A231 87 was reduced. The activity of 5-lipoxygenase was not affected by treatment with TJN-101. LTs are mainly derived from arachidonic acid which is released from the e9-position of phos pholipids by the predominant enzyme PLA2. TJN-101 suppressed the release of arachi donic acid from macrophages induced by treatment with fMet-Leu-Phe and Ca" ionophore A231 87. The activity of PLA2 was not affected by treatment with TJ N-101. From these findings, it was suggested that TJN-101 inhibited the biosynthesis of LTs in macro phages by preventing the release of arachj donic acid. Furthermore, it was reported that TJN-101 has a stabilizing effect on the plasma membrane, and it shows an inhibitory effect on the influx of 45Ca++ into liver cells (24) . These effects of TJN-101 may be related to its inhibitory effect on the release of arachi donic acid.
LTs may play a role in inflammatory liver diseases, and lipoxygenase inhibitor shows a preventive effect on experimental liver in juries. From our findings, it i's suggested that the preventive effect of TJN-101 on the arachidonic acid cascade may be associated with its inhibitory effect on liver injuries.
